KEVIN DANSBY: Open Payments
NPI 1376548040 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,320 in 64 payments from 20 companies in 2025. Trend: 2023 $1,034 · 2024 $645 · 2025 $1,320
Food & beverage: $1,320
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $275 |
| AstraZeneca Pharmaceuticals LP | 3 | $180 |
| Abbott Laboratories | 9 | $147 |
| ABBVIE INC. | 5 | $102 |
| GlaxoSmithKline, LLC. | 6 | $91 |
| Lundbeck LLC | 3 | $71 |
| PFIZER INC. | 4 | $68 |
| Xeris Pharmaceuticals, Inc. | 3 | $67 |
| Sumitomo Pharma America, Inc. | 3 | $55 |
| Axsome Therapeutics, Inc. | 2 | $46 |
Products named: Ozempic, FREESTYLE LIBRE 3, AIRSUPRA, VRAYLAR, TRELEGY ELLIPTA, VYEPTI, GVOKE HYPOPEN, GEMTESA.
Industry payments across TN — which companies pay providers there.
